Literature DB >> 23571536

Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.

Giancarlo Ceccarelli, Marco Falcone, Alessandra Giordano, Maria Lina Mezzatesta, Carla Caio, Stefania Stefani, Mario Venditti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23571536      PMCID： PMC3716145          DOI： 10.1128/AAC.00188-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

Review 1.  Surveillance and management of multidrug-resistant microorganisms.

Authors:  Giovanni Battista Orsi; Marco Falcone; Mario Venditti
Journal:  Expert Rev Anti Infect Ther       Date:  2011-08       Impact factor: 5.091

2.  Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae.

Authors:  Catharine C Bulik; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

4.  Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

Authors:  Spyros Pournaras; Georgia Vrioni; Evangelia Neou; John Dendrinos; Evangelia Dimitroulia; Aggeliki Poulou; Athanassios Tsakris
Journal:  Int J Antimicrob Agents       Date:  2011-01-13       Impact factor: 5.283

5.  Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.

Authors:  M L Mezzatesta; F Gona; C Caio; V Petrolito; D Sciortino; A Sciacca; C Santangelo; S Stefani
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

6.  Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.

Authors:  G B Orsi; A García-Fernández; A Giordano; C Venditti; A Bencardino; R Gianfreda; M Falcone; A Carattoli; M Venditti
Journal:  J Hosp Infect       Date:  2011-03-30       Impact factor: 3.926

7.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

Authors:  Mario Tumbarello; Pierluigi Viale; Claudio Viscoli; Enrico Maria Trecarichi; Fabio Tumietto; Anna Marchese; Teresa Spanu; Simone Ambretti; Francesca Ginocchio; Francesco Cristini; Angela Raffaella Losito; Sara Tedeschi; Roberto Cauda; Matteo Bassetti
Journal:  Clin Infect Dis       Date:  2012-07-02       Impact factor: 9.079

8.  Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.

Authors:  G B Orsi; A Bencardino; A Vena; A Carattoli; C Venditti; M Falcone; A Giordano; M Venditti
Journal:  Infection       Date:  2012-10-16       Impact factor: 3.553

9.  Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit.

Authors:  Francesco Sbrana; Paolo Malacarne; Bruno Viaggi; Sergio Costanzo; Piero Leonetti; Alessandro Leonildi; Beatrice Casini; Carlo Tascini; Francesco Menichetti
Journal:  Clin Infect Dis       Date:  2012-11-15       Impact factor: 9.079

10.  High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.

Authors:  A Capone; M Giannella; D Fortini; A Giordano; M Meledandri; M Ballardini; M Venditti; E Bordi; D Capozzi; M P Balice; A Tarasi; G Parisi; A Lappa; A Carattoli; N Petrosillo
Journal:  Clin Microbiol Infect       Date:  2012-11-09       Impact factor: 8.067
View more
  35 in total

Review 1.  Development of novel antibacterial drugs to combat multiple resistant organisms.

Authors:  Matteo Bassetti; Elda Righi
Journal:  Langenbecks Arch Surg       Date:  2015-02-11       Impact factor: 3.445

2.  Every cloud has a silver lining.

Authors:  Filippo Pieralli; Silvia Baroncelli; Alberto Farese; Antonio Mancini; Fabio Luise; Lucia Sammicheli; Alessandro Bartoloni; Gian Maria Rossolini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2017-05-10       Impact factor: 3.397

Review 3.  Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use.

Authors:  Phillip J Bergen; Zackery P Bulman; Sarith Saju; Juergen B Bulitta; Cornelia Landersdorfer; Alan Forrest; Jian Li; Roger L Nation; Brian T Tsuji
Journal:  Pharmacotherapy       Date:  2015-01       Impact factor: 4.705

4.  Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae.

Authors:  M Souli; I Karaiskos; A Masgala; L Galani; E Barmpouti; H Giamarellou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-16       Impact factor: 3.267

Review 5.  Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.

Authors:  Enrico Maria Trecarichi; Mario Tumbarello
Journal:  Virulence       Date:  2017-02-08       Impact factor: 5.882

6.  Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.

Authors:  Marcela Nastro; Carlos Hernan Rodríguez; Renata Monge; Jonathan Zintgraff; Liliana Neira; Mirta Rebollo; Carlos Vay; Angela Famiglietti
Journal:  J Chemother       Date:  2013-12-06       Impact factor: 1.714

7.  Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.

Authors:  Jose F Camargo; Jacques Simkins; Thiago Beduschi; Akin Tekin; Laura Aragon; Armando Pérez-Cardona; Clara E Prado; Michele I Morris; Lilian M Abbo; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-10       Impact factor: 5.191

8.  Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.

Authors:  Alessandro Russo; Simone Giuliano; Giancarlo Ceccarelli; Francesco Alessandri; Alessandra Giordano; Grazia Brunetti; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

9.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.

Authors:  Michael J Satlin; Stephen G Jenkins; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

10.  Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Authors:  Marco Falcone; Giusy Tiseo; Emanuele Durante-Mangoni; Veronica Ravasio; Francesco Barbaro; Maria Paola Ursi; Maria Bruna Pasticci; Matteo Bassetti; Paolo Grossi; Mario Venditti; Marco Rizzi
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.